Sebastian Fabritz

Sebastian Fabritz

Auto-generated profile, based on publicly available information

Sebastian Fabritz

Department for Chemical Biology, Max Planck Institute for Medical Research, Jahnstraße 29, D-69120 Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2018 in Science
Verified
Journal Article
Closed access
PDF file
QYQiuliyang Yu
Qiuliyang Yu
LXLin Xue
Lin Xue
JHJulien Hiblot
Julien Hiblot
RGRudolf Griss
Rudolf Griss
SFSebastian Fabritz
Sebastian Fabritz
KJKai Johnsson
Kai Johnsson
A protein designed to sense metabolites: Many diseases cause characteristic changes in blood metabolites. Yu et al. describe a paper-based assay in which a chosen metabolite can be oxidized to generate reduced nicotinamide adenine dinucleotide phosphate (NADPH). Color changes in a designed NADPH sensor protein are then quantified by a digital camera. The sensor system successfully generated point-of-care measurements of phenylalanine, glucose, and glutamate. Concentrations of phenylalanine in the blood of phenylketonuria patients were analyzed within minutes with only half a microliter of blood. Science , this issue p. 1122

3 September 2021 in Science Advances
Verified
Journal Article
Open access
OSOskar Staufer
Oskar Staufer
FDFranziska Dietrich
Franziska Dietrich
RRRahul Rimal
Rahul Rimal
MSMartin Schröter
Martin Schröter
SFSebastian Fabritz
Sebastian Fabritz
JSJoachim Pius Spatz
Joachim Pius Spatz
Engineered synthetic extracellular vesicles optimize cellular signaling for wound closure.

11 December 2012 in ChemBioChem
Verified
Journal Article
Closed access
PDF file
MRMichael Reinwarth
Michael Reinwarth
BGBernhard Glotzbach
Bernhard Glotzbach
MTMichael Tomaszowski
Michael Tomaszowski
SFSebastian Fabritz
Sebastian Fabritz
OAOlga Avrutina
Olga Avrutina
HKHarald Kolmar
Harald Kolmar

6 December 2012 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
SHSebastian Hörner
Sebastian Hörner
SFSebastian Fabritz
Sebastian Fabritz
HHHenry D. Herce
Henry D. Herce
OAOlga Avrutina
Olga Avrutina
CDChristian Dietz
Christian Dietz
HKHarald Kolmar
Harald Kolmar
Cube octameric silsesquioxanes (COSS) are among the smallest nanoparticles known to date with a diameter of only 0.7 nm. We describe a COSS-based delivery system which allows for the drug targeting in human cells. It comprises a siloxane core with seven pendant aminopropyl groups and a fluorescently labeled peptidic ligand attached to one cage corner via a reversible disulfide bond to ensure its intracellular release. Bimodal amplitude-modulated atomic force microscopy (AFM) experiments revealed the formation of dendritic COSS structures by a self-assembly of single particles on negatively charged surfaces. Nuclear targeting was demonstrated in HeLa cells by selective binding of released p21Cip1/Waf1-derived cargo peptide to PCNA, a protein involved in DNA replication and repair.